Logo Image
Treatment Intensification in Vulnerable Populations: ARPI Use in Elderly, Frail, and High-Comorbidity Patients With mCSPC: With Martin Schoen, MD, and Andrew W. Hahn, MD

Treatment Intensification in Vulnerable Populations: ARPI Use in Elderly, Frail, and High-Comorbidity Patients With mCSPC: With Martin Schoen, MD, and Andrew W. Hahn, MD

Featuring Martin W. Schoen, MD, MPH, Andrew W. Hahn, MD

Watch Now
Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD

Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD

Featuring David O'Malley, MD

Watch Now
Unlocking the Power of ctDNA for Residual Disease, Resistance Monitoring, and Real-Time Treatment Decisions in GI Cancers: With Christopher Lieu, MD

Unlocking the Power of ctDNA for Residual Disease, Resistance Monitoring, and Real-Time Treatment Decisions in GI Cancers: With Christopher Lieu, MD

Featuring Christopher Lieu, MD

Watch Now

Trending Videos

Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD
1

Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Commentary

Dissecting Diagnostic and Management Factors in Systemic Mastocytosis
2

Dissecting Diagnostic and Management Factors in Systemic Mastocytosis

Commentary

FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS
3

FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS

Commentary

FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO
4

FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

Commentary

Breaking Down the FDA Approval of Zanidatamab-Based Regimens in HER2+ Gastric Cancer
5

Breaking Down the FDA Approval of Zanidatamab-Based Regimens in HER2+ Gastric Cancer

Commentary

INCB161734 Holds Potential Significance for KRAS G12D–Mutated mPDAC Management
6

INCB161734 Holds Potential Significance for KRAS G12D–Mutated mPDAC Management

Commentary

Biomarker-Driven Shifts Signal the Next Generation of mCRC Therapies: With Tanios S. Bekaii-Saab, MD
7

Biomarker-Driven Shifts Signal the Next Generation of mCRC Therapies: With Tanios S. Bekaii-Saab, MD

Commentary

Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD
8

Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD

Commentary

Integrating Novel Targets and Translational Insights Into SCLC Practice: With Anne Chiang, MD, PhD
9

Integrating Novel Targets and Translational Insights Into SCLC Practice: With Anne Chiang, MD, PhD

Commentary

Pancreatic Cancer Experts Map Treatment Sequencing With Liposomal Irinotecan and Beyond
10

Pancreatic Cancer Experts Map Treatment Sequencing With Liposomal Irinotecan and Beyond

Commentary

Shorts

Riley Kandel
0:40
The OncLive Content Team Gets Creative at ESMO 2026
10 hours ago
by
Riley Kandel
Choose Your Character: ESMO Edition
0:22
Choose Your Character: ESMO Edition
3 days ago
by
Riley Kandel
Praful Ravi, MB, BChir, MRCP
1:47
Previewing Key GU Oncology Data Anticipated at ESMO 2026
3 days ago
by
Praful K. Ravi, MD
Brandon Smaglo, MD
1:03
ESMO 2026: Looking Ahead to Targeting MTAP Loss in Pancreatic Cancer
3 days ago
by
Brandon G. Smaglo, MD, FACP
Chinmay Jani, MD
1:04
Exploring Advances in Clinical Trial Design and FDA Collaboration
9 days ago
by
Chinmay Jani, MD
Chinmay Jani, MD
1:04
Building Clinical Trial Expertise Through OncLive’s Workshop
9 days ago
by
Chinmay Jani, MD
Benjamin Weinberg, MD
1:43
How the FDA Approval of Daraxonrasib Might Fuel Future Pancreatic Cancer Research
9 days ago
by
Benjamin Weinberg, MD
Ruth Moges, MD
0:48
Understanding Development From Bench to Bedside
10 days ago
by
Ruth Moges, MD
Benjamin Levy, MD
2:00
Exploring the Promise of Clinical Trials Through Inside the Trial
10 days ago
by
Benjamin P. Levy, MD
Joshua Eric Reuss, MD
0:48
Strengthening Clinical Trial Education and Collaboration Through Inside the Trial
10 days ago
by
Joshua Reuss, MD, Georgetown Lombardi Comprehensive Cancer Center

Expert Conversations

OncChats
Peer Exchange
OncLive Insights

Shows & Podcasts

View More
How This Is Building Me
Two Onc Docs
Oncology Unplugged With Dr Chandler Park
Cancer, Character, and Calling
From Discovery to Delivery: Charting Progress in Gynecologic Oncology
Breast Cancer Briefing

News & Analysis

OncLive News Network®
OncLive TV
Rapid Readouts
Biomarker Consortium